High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma
To assess the role of autologous hematopoietic cell rescue in the treatment of multiple myeloma.
Stanford is not currently accepting new patients for this trial. You may want to check clinicaltrials.gov to see if other locations are recruiting.
- procedure : high dose chemotherapy then autologous hematopoietic cell transplant
Phase: Phase 2
Ages Eligible For Study:
- received cytoreduction prior to transplant - adequate organ function